Discussants
Peter Chin-Hong, MD
University of California San Francisco
Yvonne Maldonado, MD
Stanford University
Michael S. Saag, MD
University of Alabama at Birmingham
Moderator
Paul A. Volberding, MD
University of California San Francisco
July 7, 2022
3:00 PM - 4:00 PM PTProgram Description
The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of COVID-19 and the consequences of the pandemic.
This Dialogue will provide a robust and relevant discussion of COVID-19 and SARS-CoV-2 at the time. Note, Dialogues are intended for healthcare clinicians and researchers.
- COVID-19 rebound after COVID-19 oral antiviral therapy
- The emergence of Omicron subvariants BA.4 and BA.5: Why they are different and what they mean for vaccines and the pandemic
- Current and next-generation vaccines
- Pediatric vaccines rollout in infants and their current uptake
- Monkeypox: Endemic or episodic outbreaks?
- New COVID-19 drugs
Recent Articles and Resources:
- Oral Sabizabulin for High-Risk, Hospitalized Adults with Covid-19: Interim Analysis
- Mosaic RBD Nanoparticles Protect Against Challenge by Diverse Sarbecoviruses in Animal Models
- Demographic and Clinical Characteristics of Confirmed Human Monkeypox Virus Cases in Individuals Attending a Sexual Health Centre in London, UK: An Observational Analysis
- CDC’s Monkeypox Update
- Situational Awareness: Monkeypox Outbreak—United States, June 2022
- NYC Health Department’s Interim Guidance for Treatment of Monkeypox
Sign Up
Please use the following link to sign up https://us06web.zoom.us/webinar/register/WN_SJqKDd5pSl6GUeTW1HSzvQ or click the button below.
Zoom will send an email that includes a unique link to join the Zoom activity and allow you to add this information to your calendar. Zoom will send 1-day and 1-hour reminders.